Drugs / ANTIVENIN (CROTALIDAE) POLYVALENT

Trials 2

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00868309 Jan 2005 → Aug 2006 blood coagulation disease, snakebite envenomation Instituto Bioclon S.A. de C.V. Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00636116 May 2008 → Nov 2011 snakebite envenomation Instituto Bioclon S.A. de C.V. Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as ANTIVENIN (CROTALIDAE) POLYVALENT ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Known as Anavip “The purpose of this study is to establish if F(ab)2 antivenom (Anavip) is safe for crotalinae envenomation.” NCT00636116 ↗
1

NCT00868309 ↗

Known as Crotalid antivenin (equine) ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Known as Crotaline antivenin ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Known as Crotaline antivenin, polyvalent ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Known as Immunoglobulin antivenom crotalus ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Known as Polyvalent crotalidae antivenin ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Known as Viper antivenom ChEMBL registry synonym — accepted as the source's own label CHEMBL2108851 ↗
Modality Protein / enzyme biologic “F(ab)2 antivenom” NCT00636116 ↗
Route Intravenous “Intravenous (IV)” NCT00868309 ↗